- Report
- June 2024
- 296 Pages
Global
From €2340EUR$2,450USD£1,957GBP
- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
Healthcare nanobots, within the field of nanotechnology, refer to the use of microscopic robotic devices designed to perform a variety of medical functions at the cellular or molecular level. The integration of robotics and nanoscale technologies has opened up new possibilities in diagnostics, drug delivery, and surgery. These tiny agents are engineered to navigate the human body with precision to identify and treat diseases, repair tissues, or monitor bodily functions in real time.
The applications of healthcare nanobots range from targeting cancer cells with high specificity to releasing drugs at controlled rates in the affected area. Consequently, they offer a more efficacious approach to treatment with reduced side effects compared to traditional methodologies. The development of nanobots utilizes interdisciplinary collaboration, pulling together advances in materials science, biotechnology, and computer science.
There are several companies actively working in the healthcare nanobots market. Prominent among them are Quantumzyme, which leverages nanobiotechnology for enzyme engineering; Nanobiotix, which focuses on nanomedicine for oncology; Zymergen that works on molecular manufacturing; Ginkgo Bioworks, known for its work in organism engineering and synthetic biology; and NanoRobotics, a company that specializes in developing medical robots at the nanoscale. These companies are at the forefront of transforming medical care through the innovation and application of healthcare nanobots. Show Less Read more